MFI Stock Review: Cephalon (CEPH)
By MagicDiligence on Thu, 2009-11-05 08:07
(via www.magicdiligence.com)
Cephalon has three drugs with good growth potential. If sales develop according to the company's plan, the current price will prove to be a bargain.
Recent comments
5 hours 10 min ago
6 days 17 hours ago
6 weeks 4 days ago
6 weeks 4 days ago
10 weeks 6 days ago
10 weeks 6 days ago
12 weeks 2 hours ago
12 weeks 1 day ago
14 weeks 2 days ago
14 weeks 5 days ago